Text Size
83 studies found for:    Open Studies | "Vasculitis"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Unknown † Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA Vasculitis
Condition: Vasculitis
Interventions: Drug: mycophenolate mofetil;   Drug: cyclophosphamide
2 Recruiting Prevention of Relapses in Proteinase 3 (PR3)-Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis
Condition: Vasculitis
Intervention: Drug: azathioprine
3 Recruiting Alemtuzumab for ANCA Associated Refractory Vasculitis
Conditions: Vasculitis;   Microscopic Polyangiitis;   Granulomatosis With Polyangiitis;   Wegener's
Intervention: Drug: Alemtuzumab
4 Recruiting Retinoids in ANCA Small Vessel Vasculitis: Silencing Autoantigens
Condition: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Interventions: Drug: Retinoic acid;   Drug: Standard of care
5 Not yet recruiting CMV Modulation of the Immune System in ANCA-associated Vasculitis
Conditions: ANCA Associated Vasculitis;   CMV Infection
Intervention: Drug: Valaciclovir
6 Recruiting IgA-positive Versus IgA-negative Immune Complex Vasculitis
Condition: Cutaneous Vasculitis
Intervention:
7 Not yet recruiting Rituximab Vasculitis Maintenance Study
Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis;   Microscopic Polyangiitis;   Wegener Granulomatosis
Interventions: Biological: Rituximab;   Drug: Azathioprine
8 Not yet recruiting Belimumab in Remission of VASculitis
Condition: Vasculitis
Interventions: Biological: Placebo;   Biological: Belimumab 10 mg/kg;   Drug: Azathioprine
9 Recruiting Hematopoietic Stem Cell Support in Vasculitis
Condition: Vasculitis
Intervention: Biological: Autologous Hematopoietic Stem Cell Transplant
10 Unknown † Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)
Conditions: Wegener's Granulomatosis;   Vasculitis
Interventions: Drug: mycophenolate mofetil;   Drug: cyclophosphamide
11 Recruiting A Study to Evaluate the Safety and Efficacy of CCX168 in Subjects With ANCA-Associated Renal Vasculitis
Condition: Renal Vasculitis
Interventions: Drug: Placebo;   Drug: CCX168
12 Recruiting GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic Diseases
Conditions: Lupus Erythematosus, Systemic;   Systemic Vasculitis;   Isolated Angiitis of Central Nervous System;   Lung Disease With Systemic Sclerosis;   Lung Disease Interstitial Diffuse
Interventions: Drug: depot leuprolide acetate 3.75 mg;   Drug: Placebo
13 Recruiting Carotid Artery Neovascularization in Takayasu's and Giant Cell Arteritis
Conditions: Takayasu's Arteritis;   Giant Cell Arteritis;   Arteritis;   Vasculitis;   Aortitis
Intervention:
14 Recruiting Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis
Conditions: Granulomatosis With Polyangiitis (Wegener's) (GPA);   Microscopic Polyangiitis (MPA)
Interventions: Procedure: Plasma Exchange;   Drug: Glucocorticoids
15 Not yet recruiting BIANCA-SC: A Study of the Efficacy, Safety, and Tolerability of Blisibimod in Addition to Methotrexate During Induction of Remission in Subjects With ANCA-Associated Small Vessel Vasculitis
Conditions: Granulomatosis With Polyangiitis;   Microscopic Polyangiitis
Interventions: Drug: Blisibimod;   Drug: Placebo
16 Unknown † Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet`s Disease (INCYTOB)
Conditions: Behcet's Disease;   Panuveitis;   Posterior Uveitis;   Retinal Vasculitis
Interventions: Drug: Cyclosporin A;   Drug: Interferon-alpha2a
17 Recruiting American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis
Conditions: Wegener's Granulomatosis;   Microscopic Polyangiitis;   Churg Strauss Syndrome;   Polyarteritis Nodosa;   Giant Cell Arteritis;   Takayasu Arteritis
Intervention:
18 Recruiting The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease
Conditions: Uveitis;   Vasculitis;   Ocular Inflammatory Disease
Intervention:
19 Recruiting Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis
Conditions: Granulomatosis With Polyangiitis;   Microscopic Polyangiitis;   Renal Limited Forms
Interventions: Drug: Rituximab (Arm B);   Drug: Rituximab (Arm A)
20 Recruiting One-Time DNA Study for Vasculitis
Conditions: Churg-Strauss Syndrome;   Giant Cell Arteritis;   Granulomatosis With Polyangiitis (Wegener's);   Microscopic Polyangiitis;   Polyarteritis Nodosa;   Takayasu's Arteritis
Intervention:
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years